Patent Defendant: Reliance On Sunovion By Delaware Judge Is Reversible Error
WASHINGTON, D.C. — Two pharmaceutical companies embroiled in a patent dispute over a sodium chloride solution of the drug dexmedetomidine (“dex”) presented in a sealed glass container recently briefed the Federal...To view the full article, register now.
Already a subscriber? Click here to view full article